HIV 'superinfection' boosts immune response
Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody responses that block the replication of the virus ...
HIV & AIDS
Mar 29, 2012 |
5 / 5 (3) |
0
|
Bright future ahead for antibody cancer therapy
Antibodies, once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way, say cancer researchers at the Georgetown Lombardi Comprehensive Cancer Center
Cancer
Mar 15, 2012 |
5 / 5 (4) |
0
|
New research could significantly reduce the need for clinical animal testing
University of Southampton researchers are investigating innovative methods of testing drugs that will reduce the need for involving animals.
Immunology
Mar 08, 2012 |
1 / 5 (1) |
0
Antibodies are not required for immunity against some viruses
A new study turns the well established theory that antibodies are required for antiviral immunity upside down and reveals that an unexpected partnership between the specific and non-specific divisions of the immune system ...
Immunology
Mar 01, 2012 |
not rated yet |
0
|
Researchers take a step forward in transplanting pig cells to regenerate human cartilage
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have studied for the first time the response of human NK cells (Natural Killer) against porcine chondrocytes (cartilage cells).
Medical research
Feb 22, 2012 |
5 / 5 (2) |
0
PFCs, chemicals in environment, linked to lowered immune response to childhood vaccinations
A new study finds that perfluorinated compounds (PFCs), widely used in manufactured products such as non-stick cookware, waterproof clothing, and fast-food packaging, were associated with lowered immune response to vaccinations ...
Immunology
Jan 24, 2012 |
4 / 5 (1) |
0
|
Experimental vaccine partially protects monkeys from HIV-like infection
Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys. In addition, in the animals that became infected, ...
HIV & AIDS
Jan 04, 2012 |
not rated yet |
0
|
Another potential obstacle to developing an HIV vaccine
A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work.
HIV & AIDS
Dec 27, 2011 |
2 / 5 (2) |
0
Cell membrane proteins could provide targets for broader vaccines
Vaccines with broader reach might be made by stimulating specialized immune cells to recognize foreign cell membrane proteins that are shared across bacterial species, say researchers from Children's Hospital of Pittsburgh ...
Medical research
Dec 22, 2011 |
4.7 / 5 (3) |
0
|
Natural killers help fight human disease
(Medical Xpress) -- Researchers from The Australian National University have discovered a new type of cell which boosts the human body’s ability to fight off infections and life-threatening diseases.
Medical research
Nov 28, 2011 |
5 / 5 (3) |
0
|
IADR/AADR publish study on dental caries vaccine
In a report on a preclinical investigation titled "Flagellin Enhances Saliva IgA Response and Protection of Anti-caries DNA Vaccine," lead author Wei Shi, Wuhan Institute of Virology, Chinese Academy of Sciences, and his ...
Other
Oct 25, 2011 |
not rated yet |
0
Researchers discuss challenges to developing broadly protective HIV vaccines
The human body can produce powerful antibodies that shield cells in the laboratory against infection by an array of HIV strains. In people, however, recent research shows that these broadly neutralizing antibodies are not ...
HIV & AIDS
Sep 07, 2011 |
5 / 5 (1) |
0
Researchers isolate new potent and broadly effective antibodies against HIV
A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, ...
HIV & AIDS
Aug 17, 2011 |
5 / 5 (1) |
0
|
Any prime-boost mix of injected or spray flu vaccine shields toddlers
Children younger than 3 years old receive the same protective antibody response from the recommended two doses of licensed seasonal influenza vaccines regardless of whether the two doses are injected by needle, ...
Diseases, Conditions, Syndromes
Aug 16, 2011 |
not rated yet |
0
|
Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses
A paper published today in the scientific research journal Science, describes a novel, proprietary monoclonal antibody (FI6) discovered in a collaboration between Humabs BioMed SA, the Institute for Research in Biomedicine ("IRB" ...
Medical research
Jul 28, 2011 |
5 / 5 (1) |
0
|
